New drugs aim to stop deadly clots in leg artery patients
NCT ID NCT07318610
Summary
This large study is testing two new antibody drugs, REGN7508 and REGN9933, to prevent life-threatening blood clots in people with narrowed leg arteries who just had surgery to improve blood flow. The study will compare these new drugs against both a standard blood thinner (rivaroxaban) and a placebo (inactive substance) in over 7,000 participants. Researchers want to see if the new drugs can prevent serious complications like heart attacks, strokes, and amputations while causing fewer bleeding problems than current treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE (PAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.